Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125266411 | 12526641 | 1 | I | 20160621 | 20160705 | 20160705 | EXP | GB-NOVEL LABORATORIES, INC-2016-02898 | NOVEL LABS | IFTIKHAR H, CRAVEN H, BHATNAGAR P. PROFOUND OPIATE TOXICITY IN GASTROPARESIS FOLLOWING THERAPEUTIC DOSE. BMJ CASE REPORTS. 2016;. | 20.00 | YR | F | Y | 0.00000 | 20160705 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125266411 | 12526641 | 1 | PS | Morphine | MORPHINE | 1 | Intravenous (not otherwise specified) | UNKNOWN | 203602 | 2.5 | MG | ||||||||
| 125266411 | 12526641 | 2 | SS | Morphine | MORPHINE | 1 | Oral | UNKNOWN | 203602 | 20 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125266411 | 12526641 | 1 | Abdominal pain |
| 125266411 | 12526641 | 2 | Abdominal pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125266411 | 12526641 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125266411 | 12526641 | Condition aggravated | |
| 125266411 | 12526641 | Impaired gastric emptying | |
| 125266411 | 12526641 | Respiratory depression | |
| 125266411 | 12526641 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |